Treatment Considerations in Relapsed Refractory Multiple Myeloma

EP. 1: Dr. Mikhael on Treatment Selection for Early Relapse in Multiple Myeloma

August 9th 2021

Joseph Mikhael, MD, discusses treatment selection for early relapse in multiple myeloma.

EP. 2: Dr. Lentzsch on the Utility of Cellular Therapies in Multiple Myeloma

August 9th 2021

Suzanne Lentzsch, MD, discusses the utility of cellular therapies in multiple myeloma.

EP. 3: Dr. Martin on the Utility of Quadruplet-Based Regimens in Relapsed/Refractory Multiple Myeloma

September 10th 2021

Thomas G. Martin, MD, discusses the potential utility of quadruplet-based regimens in relapsed/refractory multiple myeloma.

EP. 4: Treatment Considerations in Relapsed/Refractory Multiple Myeloma

September 29th 2021

EP. 5: Dr. Lentzsch on How Patient Age Informs Treatment Decisions in Multiple Myeloma

November 12th 2021

Suzanne Lentzsch, MD, discusses how patient age informs treatment decisions in multiple myeloma.

EP. 6: Dr. Mikhael on the Promise of Bispecific Antibodies in Multiple Myeloma

November 12th 2021

Joseph Mikhael, MD, discusses the promise of bispecific antibodies in multiple myeloma.

EP. 7: Dr. Martin on the Utility of CAR T-Cell Therapy in Late Relapsed Multiple Myeloma

November 12th 2021

Thomas G. Martin, MD, discusses the utility of CAR T-cell therapy in late relapsed multiple myeloma.